SEC 13F Intelligence

Glenmede Trust Co Na / ABT

Glenmede Trust Co Na’s Abbott Laboratories Position

Does Glenmede Trust Co Na own Abbott Laboratories (ABT)? Yes — 1.07M shares worth $110M (+0.54% of its 13F portfolio) as of Q1 2026, down from 1.13M shares the prior filed quarter.

Position Value
$110M
Q1 2026
Shares
1.07M
% of Portfolio
+0.54%
Quarters Held
28
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $95MQ4 ’18Q1 ’19: $105MQ2 ’19: $107MQ3 ’19: $99MQ4 ’19: $106MQ4 ’19Q1 ’20: $106MQ2 ’20: $114MQ3 ’20: $137MQ4 ’20: $134MQ4 ’20Q1 ’21: $157MQ2 ’21: $154MQ3 ’21: $157MQ4 ’21: $186MQ4 ’21Q1 ’22: $160MQ2 ’22: $177MQ3 ’22: $138MQ4 ’22: $190MQ4 ’22Q1 ’23: $170MQ2 ’23: $170MQ3 ’23: $143MQ4 ’23: $165MQ4 ’23Q1 ’24: $173MQ2 ’24: $160MQ3 ’24: $173MQ4 ’24: $154MQ4 ’24Q1 ’25: $174MQ4 ’25: $142MQ1 ’26: $110Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.07M$110M+0.54%
Q4 20251.13M$142M+0.67%
Q1 20251.31M$174M+0.93%
Q4 20241.37M$154M+0.79%
Q3 20241.52M$173M+0.83%
Q2 20241.54M$160M+0.81%
Q1 20241.52M$173M+0.87%
Q4 20231.50M$165M+0.86%
Q3 20231.48M$143M+0.82%
Q2 20231.68M$170M+0.96%
Q1 20231.68M$170M+0.96%
Q4 20221.73M$190M+1.12%
Q3 20221.42M$138M+0.87%
Q2 20221.63M$177M+1.04%
Q1 20221.35M$160M+0.78%
Q4 20211.32M$186M+0.88%
Q3 20211.32M$157M+0.81%
Q2 20211.32M$154M+0.79%
Q1 20211.31M$157M+0.85%
Q4 20201.22M$134M+0.74%
Q3 20201.26M$137M+0.82%
Q2 20201.24M$114M+0.69%
Q1 20201.22M$106M+0.48%
Q4 20191.22M$106M+0.48%
Q3 20191.19M$99M+0.45%
Q2 20191.27M$107M+0.47%
Q1 20191.31M$105M+0.47%
Q4 20181.32M$95M+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenmede Trust Co Na’s full portfolio or all institutional holders of ABT.